Johnson & Johnson has been fighting pandemics for over a century. With our global reach comes a responsibility and unique ability to leverage our deep scientific expertise and extensive partnerships to take on this challenge. Employees around the world are mobilizing with urgency to address the critical needs of families, communities, and healthcare providers working toward mitigating and ultimately helping end the COVID-19 pandemic. If proven safe and effective, Johnson & Johnson expects to deliver its vaccine at a rate of one billion doses per year by the end of 2021. This feat requires extensive collaboration and innovation from Johnson & Johnson Technology and across the enterprise.